Back

Mirati Therapeutics Stock Predictions

A 100% Win Rate In 2022

Click to see this exclusive sit-down interview

Sell

MRTX
Mirati Therapeutics

Last Price:

39.07

Seasonality Move:

-0.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Kiyosaki WARNS: the economy is the 'biggest bubble' in history

Ready to dump your paper assets? Get Your Free Gold & Silver Guide Now

Mirati Therapeutics Stock Forecast

Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 66.8% based on the past 9 years of stock performance.
Mirati Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Is Mirati Therapeutics Stock Undervalued?
The current Mirati Therapeutics [MRTX] share price is $39.10. The Score for MRTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
MRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Mirati Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 66.8% based on the past 9 years of stock performance.

Mirati Therapeutics Stock Rating

Sell

Mirati Therapeutics (MRTX) is a Sell

Is Mirati Therapeutics overpriced?

Mirati Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Mirati Therapeutics Stock Price History

Is MRTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Healthcare

Type:

stock

Website:

mirati.com

52-Week Data

52-Week High:

101.30

52-Week Low:

32.96

Prediction Charts

Market Cap:

2.27B

Price in USD:

39.10

Volume:

1.12M

Beta:

1.25

Technical Analysis

SMA50:

45.90

SMA100:

53.26

SMA200:

61.90

52-Wk Change:

-52.42%

Stock Predictions

Is Mirati Therapeutics stock public?
Yes, Mirati Therapeutics is a publicly traded company.
What is the Mirati Therapeutics stock quote today?
The Mirati Therapeutics stock price is 39.10 USD today.
How to buy Mirati Therapeutics stock online?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-7	41.61	41.78	42.64	41.12
Mar-8	41.54	41.67	41.92	41.08
Mar-9	41.67	40.75	42.43	40.39
Mar-10	40.86	39.22	40.86	38.40
Mar-13	38.95	39.08	40.09	38.53
Mar-14	40.23	44.40	44.42	39.73
Mar-15	44.13	43.15	45.91	41.15
Mar-16	42.88	42.87	43.38	41.03
Mar-17	42.79	41.40	42.79	40.94
Mar-20	42.08	40.53	42.08	40.37
Mar-21	40.60	40.72	41.62	40.17
Mar-22	40.64	39.54	40.79	39.28
Mar-23	39.99	38.77	40.39	38.12
Mar-24	38.49	39.10	39.19	36.92

Mirati Therapeutics Earnings

Mirati Therapeutics Earnings Report: Per Share Mirati Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mirati Therapeutics Forecast Revenue Growth

Mirati Therapeutics Stock Analysis: Historical quarterly revenues per share for Mirati Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $2.26 per share.

* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.